Translations are provided for information and are not official versions issued by the organiser. Official names, sources and documents are retained. Translation does not constitute a medical review.
Medical Oncology
Preview
ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2027: Lugano
European Society for Medical Oncology (ESMO)
23 March 2027 – 24 March 2027
Lugano, Switzerland
Congress facts
Dates, locations, invitations, programmes and official registration links are public. Membership is required only for summary contents and participant names.
Source links appear beside the relevant field. A ‘calendar reference’ supports the record as a whole; it does not mean every field was verified separately. Unknown information is not guessed.
Official name / calendar name
ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2027: LuganoCalendar reference ↗
ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2027: Lugano
Organiser
European Society for Medical Oncology (ESMO)
Date
23 March 2027 – 24 March 2027
Location
Lugano, Switzerland
Specialty
Medical Oncology
Summary mode
Preview
Source check
24 September 2026
The official organiser page was reviewed in two independent checks on 25 September 2026; the date and city are explicitly stated in that source. Source: https://www.esmo.org/meeting-calendar/esmo-advanced-course-on-the-evolving-role-of-cdk4-6-inhibitors-in-hormone-receptor-positive-her2-negative-early-and-advanced-breast-cancer-2027-lugano. This is calendar information; consult the official congress website for the scientific programme and registration conditions. This record is not presented as a medical review by a physician.
Attendance
Mark that you plan to attend. Your name remains hidden unless you choose to share it.
When is ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2027: Lugano?
Dates in the calendar record: 23 March 2027 – 24 March 2027. Check the official source for changes or cancellations.
Where is ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2027: Lugano held?
Location in the calendar record: Lugano, Switzerland.
Who organises ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2027: Lugano?
Organiser: European Society for Medical Oncology (ESMO).
Where can I find the official website and registration information?
Official congress website: https://www.esmo.org/meeting-calendar/esmo-advanced-course-on-the-evolving-role-of-cdk4-6-inhibitors-in-hormone-receptor-positive-her2-negative-early-and-advanced-breast-cancer-2027-lugano. Registration and programme information are published on the official website.